Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | WRN | Q14191 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | GSK3A | P49840 | 2/20 | 0.31 |
| ▸ | GSK3B | P49841 | 2/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15665488 | 0.87 | MGLL (0.45) | MGLLALDH1A1GAAMAPTMAPK1 | |
| SCHEMBL16632727 | 0.87 | MGLL (0.45) | MGLLALDH1A1GAAMAPTMAPK1 | |
| Methyl Alcohol SCHEMBL28042472 | 0.84 | MGLL (0.42) | MGLLALDH1A1BLMHPGDGAA | |
| SCHEMBL28453296 | 0.78 | MGLL (0.54) | MGLLALDH1A1BLMHPGDGAA | |
| SCHEMBL25486768 | 0.76 | MGLL (0.37) | MGLLALDH1A1BLMHPGDGAA | |
| SCHEMBL26143941 | 0.76 | MGLL (0.42) | MGLLALDH1A1BLMHPGDGAA | |
| SCHEMBL7584719 | 0.74 | ALDH1A1 (0.36) | MGLLALDH1A1BLMHPGDGAA | |
| SCHEMBL14868175 | 0.74 | MGLL (0.61) | MGLLALDH1A1BLMHPGDFAAH | |
| Acetic Acid SCHEMBL7097518 | 0.71 | ALDH1A1 (0.34) | MGLLALDH1A1BLMHPGDGAA | |
| SCHEMBL17173822 | 0.71 | ALDH1A1 (0.40) | MGLLALDH1A1BLMLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2750 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216271-A1 | HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF | GEORGIA TECH RESEARCH CORPORATION | 2024-07-04 | — | — | US | claimed |
| WO-2024081793-A1 | INGESTIBLE IN VIVO-ASSEMBLING DRUG RELEASE FORMULATIONS AND METHODS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-04-18 | — | — | WO | claimed |
| EP-4351671-A2 | HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF | Georgia Tech Research Corporation (US) | 2024-04-17 | — | — | EP | claimed |
| CN-117897400-A | Polyethylene glycol derivative modified interleukin 12 and preparation method and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117795005-A | Hydrolytically degradable hydrogels and their use | 佐治亚科技研究公司 | 2024-03-29 | — | — | CN | claimed |
| CN-114196505-B | Rare cell capturing device and preparation method thereof | 江苏汇先医药技术有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-117603335-A | Human serum amyloid A mutant | 北京春雷杰创生物科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| EP-4324485-A1 | A METHOD FOR THE PRODUCTION OF PEGYLATED HYPERBRANCHED POLY( -AMINO ESTER)S, PEGYLATED HYPERBRANCHED POLY( -AMINO ESTER)S PRODUCED BY THOSE METHODS AND THEIR USE IN ENHANCED NUCLEIC ACID DELIVERY | Branca Banus Ltd (IE) | 2024-02-21 | — | — | EP | claimed |
| WO-2023212160-A1 | DRUG RELEASING HYDROGELS, MATERIALS, DEVICES, AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2023-11-02 | — | — | WO | claimed |
| CN-116496511-A | Macroporous hydrogel with rapid degradation of enzyme response and preparation method and application thereof | 南京大学 | 2023-07-28 | — | — | CN | claimed |
| CN-101166545-A | GLP-1 pegylated compounds | LILLY CO ELI (US) | 2008-04-23 | — | — | CN | claimed |
| EP-1345982-B1 | SYNTHESIS OF HIGH MOLECULAR WEIGHT NON-PEPTIDIC POLYMER DERIVATIVES | NEKTAR THERAPEUTICS AL CORP (US) | 2007-04-25 | — | — | EP | claimed |
| EP-1711207-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | Medarex, Inc. (US) | 2006-10-18 | — | — | EP | claimed |
| WO-2005059106-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | MEDAREX, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| US-6410017-B1 | PERSONAL CARE WIPE COMPOSITION COMPRISING WATER INSOLUBLE SUBSTRATE, PLURALITY OF ACTIVE PROTEINS, AND BINDING MEANS, COMPRISING POLYMERIC TETHER, PERMANENTLY ATTACHING EACH ENZYME TO SUBSTRATE | THE PROCTER & GAMBLE COMPANY | 2002-06-25 | — | — | US | claimed |
| US-6303119-B1 | WIPES AND SKIN MASKS. | THE PROCTER & GAMBLE COMPANY | 2001-10-16 | — | — | US | claimed |
| EP-1115366-A2 | PERSONAL CARE COMPOSITIONS CONTAINING ACTIVE PROTEINS TETHERED TO A WATER INSOLUBLE SUBSTRATE | The Procter & Gamble Company (US) | 2001-07-18 | — | — | EP | claimed |
| EP-1115376-A1 | PERSONAL CARE COMPOSITIONS CONTAINING SUBTILISIN ENZYMES BOUND TO WATER INSOLUBLE SUBSTRATES | THE PROCTER & GAMBLE COMPANY (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2000016740-A1 | PERSONAL CARE COMPOSITIONS CONTAINING SUBTILISIN ENZYMES BOUND TO WATER INSOLUBLE SUBSTRATES | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-30 | — | — | WO | claimed |
| WO-2000016733-A2 | PERSONAL CARE COMPOSITIONS CONTAINING ACTIVE PROTEINS TETHERED TO A WATER INSOLUBLE SUBSTRATE | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-30 | — | — | WO | claimed |